Lund Sept 13, 2011
On Wednesday September 14 the new clinic Nuklearmedizin Wandsbek Markt in Hamburg opens. The clinic will be one of the leading privately held clinics in Germany within cardiac diagnostics. In order to reach this ambition, the company has chosen EXINI heart™.
EXINIs latest customer - Nuklearmedizin Wandsbek Markt - holds an opening ceremony of their new clinic in Hamburg this Wednesday. Staff from EXINI is attending the ceremony and the following symposium, where several well known and interesting speakers are present. Among the speakers is Dr Oliver Lindner from Bad Oeynhausen, who already cooperates with EXINI within research of the company’s product EXINI heart™.
The principal parts of the symposium are modern imaging diagnosis with reduced amount of radiation. EXINI heart™ is in line with Nuklearmedizin Wandsbek Markt’s ambition to be one of the leading private clinics in Germany for cardiac diagnostics. The system has been bought and installed at the clinic.
For more information, please contact:
Magnus Aurell, CEO
Phone: +46 46-286 54 25
E-mail: magnus.aurell@exini.com
About EXINI Diagnostics AB (publ) EXINI Diagnostics AB (publ) offers advanced solutions for medical decision support to hospitals worldwide. The system is based on advanced image analysis by artificial intelligence and can make their own interpretation of radiology images and providing diagnostic suggestions. In this way the system is used as a decision support for diagnosing sparkling doctor. EXINI working on products for the diagnosis of some of the most frequent endemic diseases such as coronary heart disease, cancer, dementia and Parkinson's disease. Founded in 1999 by Professor Lars Edenbrandt and currently has 13 employees. EXINI is listed on the stock market square and has about 400 shareholders. Principal owner, Bo Håkansson.
EXINI Diagnostics AB, Ideon Science Park, Scheelevägen 19A, SE-223 70 Lund, Sweden Phone: +46 46 286 54 20, Fax: +46 46 286 54 29, info@exini.com, www.exini.com, VAT-no: SE556576199501